Abstract:Management of low-risk thyroid carcinoma has been the hotspot in the field of thyroid malignancy. Although the management guidelines for the patients with low-risk thyroid carcinoma standardize the diagnosis and therapy, there still are some controversies. Because of the favorable prognosis of low-risk thyroid carcinoma, it's difficult to choose the optimal treatment from clinical follow-up, surgery in early stage or minimally invasive technology. However, radiofrequency ablation was controversial currently in the management of low-risk thyroid carcinoma more researches are necessary to guide the optimal treatment strategy for low-risk thyroid carcinoma. In line with the principle of comprehensive and standardized treatment, the treatment of low-risk thyroid cancer requires communication between doctors and patients, and a truly individualized treatment strategy based on the tumor, the patient's social psychological factors and other factors.
